Company Financials

TransMedics Group, Inc. Financials

United States dollar

business TransMedics Group, Inc. Company Profile

Main Stock Listing

NASDAQ: TMDX

Market Capitalization $4.19 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 47.89
Forward PE 41.75
Price to Sales TTM $7.34
Price to Book MRQ $11.69
Enterprise to Revenue 7.43
Enterprise to EBITDA 34.93

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 16.20%
Operating Margin 16.20%
Return on Assets TTM 6.93%
Return on Equity TTM 32.48%

Income Statement

Revenue TTM $566,353,984
Revenue per Share TTM $16.74
Quarterly Revenue Growth 32.20%
Gross Profit TTM $341,404,992
EBITDA $131,574,000
Net Income to Common TTM $91,765,000
Diluted EPS TTM $2.54
Quarterly Earnings Growth YoY 476.80%

Balance Sheet

Total Cash MRQ $466,174,016
Total Cash per Share MRQ $13.64
Total Debt MRQ $
Total Debt to Equity MRQ 146.21
Current Ratio MRQ 7.69
Book Value per Share MRQ $10.40

Cash Flow

Operating Cash Flow TTM $177,990,000
Levered Free Cash Flow TTM $87,045,872

TMDX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 34,144,977
Float Shares 33,027,435
Avg 10 Volume 615,020
Avg 30 Volume None
Shares Short 6,996,469
Short Ratio 8.06
Short % of Shares 35.11%
% Held by Insiders 2.95%
% Held by Institutions 111.18%

Stock Price Summary

Beta 2.05
Fifty Two Week Low $55.00
Fifty Two Week High $156.00
Fifty Two Week Change 38.36%
Day 50 MA $128.53
Day 200 MA $114.86

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date